The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

Ketamine and the use of other psychedelics for mental health disorders has become a more mainstream topic over the past few ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

The following is a summary of “Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Celebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...